About TB-500 Script — a scriptorium for the research record.
What this project is, what "script" means here, and the firm line between summarizing a literature and prescribing from it.
What TB-500 Script is
TB-500 Script works like a scriptorium for the published research on Thymosin Beta-4 and its Ac-LKKTETQ fragment: a copyist's desk that transcribes what the studies say, sets each passage in plain terms, and keeps the citation in the margin. The only 'script' written here is a faithful copy of the record. It is a reading desk, not a prescriber and not a shop — nothing is sold, supplied, dosed, or dispensed, no prescription is written, no appointment is taken, and no clinical staff stands behind it. No page carries medical direction.
What "script" means here
'Script' plays on the prescription sense of the word, but here it means the written record — the manuscript of the evidence — not a prescription you can fill. The site issues no script in the clinical sense and supplies no peptide. What the scriptorium copies out is the state of the science: where mechanism is established, where human data are missing, and where product claims run past what the studies support. That distinction is drawn openly so the name is never taken as an offer.
How we handle the evidence
Every transcribed line carries its source. A quantitative claim is copied only against a specific peer-reviewed study, registered trial, or regulatory document, and each reference is checkable on /references. Failed replications and negative findings are transcribed beside the favorable ones, and vendor copy that fuses the synthetic fragment with full-length Tβ4 is corrected against the structural record. No seller is linked; the desk points outward only to PubMed, PubMed Central, ClinicalTrials.gov, the NIH, journals, and the agencies of record.